Results 11 to 20 of about 204,846 (354)

Mechanisms of Autoantibody-Induced Pathology [PDF]

open access: yesFrontiers in Immunology, 2017
Autoantibodies are frequently observed in healthy individuals. In a minority of these individuals, they lead to manifestation of autoimmune diseases, such as rheumatoid arthritis or Graves’ disease.
R. Ludwig   +23 more
semanticscholar   +2 more sources

Effectiveness of pirfenidone in idiopathic pulmonary fibrosis according to the autoantibody status: a retrospective cohort study [PDF]

open access: yesBMC Pulmonary Medicine, 2021
Background Pirfenidone is an anti-fibrotic agent shown to slow the progression of idiopathic pulmonary fibrosis (IPF). However, its effectiveness in association with serological autoimmune features in IPF remains unclear.
Myung Jin Song   +7 more
doaj   +2 more sources

Enhanced treatment strategies and distinct disease outcomes among autoantibody-positive and -negative rheumatoid arthritis patients over 25 years: A longitudinal cohort study in the Netherlands.

open access: yesPLoS Medicine, 2020
BackgroundBased on different genetic and environmental risk factors and histology, it has been proposed that rheumatoid arthritis (RA) consists of 2 types: autoantibody-positive and autoantibody-negative RA. However, until now, this remained hypothetical.
Xanthe M E Matthijssen   +3 more
doaj   +2 more sources

Advanced Autoantibody Testing in Systemic Sclerosis [PDF]

open access: yesDiagnostics, 2023
Systemic sclerosis is a systemic autoimmune rheumatic disease characterized by immune abnormalities, leading to vasculopathy and fibrosis. Autoantibody testing has become an increasingly important part of diagnosis and prognostication.
Kholoud Almaabdi   +2 more
doaj   +2 more sources

The Relationship between Serum Carbonic Anhydrase I-II Autoantibody Levels and Diabetic Retinopathy in Type 1 Diabetes Patients

open access: yesTürk Oftalmoloji Dergisi, 2017
Objectives: To investigate the relationship between serum carbonic anhydrase I-II (CA-I and II) autoantibody levels and diabetic retinopathy (DRP) in cases with type 1 diabetes. Materials and Methods: A total of 37 type-1 diabetic patients, 17 with DRP (
Adem Türk   +6 more
doaj   +2 more sources

First-emerging islet autoantibody and glucose metabolism: search for type 1 diabetes subtypes [PDF]

open access: yesEndocrine Connections, 2022
Objective: Subtypes in type 1 diabetes pathogenesis have been implicated based on the first-appearing autoantibody (primary autoantibody). We set out to describe the glucose metabolism in preclinical diabetes in relation to the primary autoantibody in ...
Olli Helminen   +6 more
doaj   +2 more sources

Autoantibody pain [PDF]

open access: yesAutoimmunity Reviews, 2016
As autoantibodies bind to target tissues, Fc-region dependent inflammation can induce pain via mediators exciting nociceptors. But recently another possibility has emerged, where autoantibody binding to nociceptors can directly cause pain, without inflammation.
Goebel, Andreas
openaire   +3 more sources

Autoantigen Microarray for High-throughput Autoantibody Profiling in Systemic Lupus Erythematosus

open access: yesGenomics, Proteomics & Bioinformatics, 2015
Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by the production of autoantibodies to a broad range of self-antigens. Profiling the autoantibody repertoire using array-based technology has emerged as a powerful tool for ...
Honglin Zhu   +4 more
doaj   +2 more sources

Immune network dysregulation in rheumatoid arthritis and systemic lupus erythematosus: cytokine signatures, autoantibody profiles, and implications for precision medicine [PDF]

open access: yesFrontiers in Medicine
BackgroundRheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are systemic autoimmune diseases characterized by chronic inflammation, immune dysregulation, and heterogeneous clinical manifestations. Despite differences in target organs, both
Benjuan Wu, Liya Zhang, Fuxi Chen
doaj   +2 more sources

Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells

open access: yesNature Biotechnology, 2023
Muscle-specific tyrosine kinase myasthenia gravis (MuSK MG) is an autoimmune disease that causes life-threatening muscle weakness due to anti-MuSK autoantibodies that disrupt neuromuscular junction signaling.
Sangwook Oh   +18 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy